ATE121945T1 - Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma. - Google Patents

Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma.

Info

Publication number
ATE121945T1
ATE121945T1 AT91901503T AT91901503T ATE121945T1 AT E121945 T1 ATE121945 T1 AT E121945T1 AT 91901503 T AT91901503 T AT 91901503T AT 91901503 T AT91901503 T AT 91901503T AT E121945 T1 ATE121945 T1 AT E121945T1
Authority
AT
Austria
Prior art keywords
gamma interferon
steroid
dependent asthma
medication
producing
Prior art date
Application number
AT91901503T
Other languages
English (en)
Inventor
Donald Y M Leung
Raif S Geha
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23766250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE121945(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of ATE121945T1 publication Critical patent/ATE121945T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91901503T 1989-12-01 1990-11-29 Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma. ATE121945T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44476389A 1989-12-01 1989-12-01

Publications (1)

Publication Number Publication Date
ATE121945T1 true ATE121945T1 (de) 1995-05-15

Family

ID=23766250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901503T ATE121945T1 (de) 1989-12-01 1990-11-29 Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma.

Country Status (8)

Country Link
EP (1) EP0502997B1 (de)
JP (1) JP2901017B2 (de)
AT (1) ATE121945T1 (de)
CA (1) CA2069870E (de)
DE (1) DE69019163T2 (de)
DK (1) DK0502997T3 (de)
ES (1) ES2071977T3 (de)
WO (1) WO1991007984A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
BR9909422A (pt) 1998-04-02 2001-09-11 Genentech Inc Método para tratamento de hipertrofia cardìaca, método para preparação de composição farmacêutica para o tratamento de hipertrofia cardìaca e seu produto farmacêutico
JP2003513933A (ja) * 1999-11-10 2003-04-15 モンドバイオテック・ソシエテ・アノニム 喘息治療用インターフェロンガンマ
JP4435465B2 (ja) * 2002-08-05 2010-03-17 長岡 均 抗アレルギー剤
EP1430902A1 (de) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Pharmazeutische Zusammensetzung enthaltend gamma-interferon zusammen mit molekularischen diagnostischen Methoden zur verbesserten Behandlung von Asthma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
JPH01502980A (ja) * 1986-06-17 1989-10-12 レイチ，スティーブン　デー ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法

Also Published As

Publication number Publication date
EP0502997B1 (de) 1995-05-03
CA2069870C (en) 2000-08-22
JP2901017B2 (ja) 1999-06-02
CA2069870A1 (en) 1991-06-02
ES2071977T3 (es) 1995-07-01
JPH05501716A (ja) 1993-04-02
WO1991007984A1 (en) 1991-06-13
DE69019163D1 (de) 1995-06-08
CA2069870E (en) 2005-01-11
DE69019163T2 (de) 1995-09-07
DK0502997T3 (da) 1995-07-17
EP0502997A1 (de) 1992-09-16

Similar Documents

Publication Publication Date Title
Brooke Art therapy: An approach to working with sexual abuse survivors.
DE69513167D1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
ATE217533T1 (de) Verwendung von il-12 und il-12 antagonisten zur herstellung eines arzneimittels für behandlung von autoimmunkrankheiten
ATE210979T1 (de) Verwendung rapamycin zur herstellung eines medikaments für die verbeugung und behandlung von hyperproliferativen gefässerkrankheiten, eventuell in kombination mit mycophenolsäure
DE69429527D1 (de) Inhibitoren von beta-amyloid-protein-herstellung
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2168006T3 (es) Factor neurotrofico ciliar modificado, metodo de fabricacion y metodos de utilizacion.
DE69014396D1 (de) Verfahren zur Herstellung von permeationsbeständigen Silikonelastomer enthaltenden Mehrschichtstrukturen sowie dadurch hergestellte Artikel.
ATE324884T1 (de) Verwendung von gamma-linolensäure oder dihomogammalinolensäure zur herstellung eines medikaments zur behandlung von huntington's chorea
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
ATE92061T1 (de) Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten.
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE68900371D1 (de) Textile struktur zur herstellung von schichtstoffen und schichtformteile, die diese struktur enthalten.
ATE121945T1 (de) Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma.
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
ATE84877T1 (de) Verfahren zur kristallmorphologischen blut- und harnanalyse, zur fruehdiagnose und zur herstellung von arzneimitteln.
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
EP0383171A3 (de) 2,3,23-Trihydroxy-urs-12-en Derivate zur Behandlung von Kognitiven Störungen
BE890954A (fr) Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked